Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy.
Principal Investigator
Sang-Young Ryu, MD
Status
Closed to Accrual
Date Opened To Accrual
April 12 2010
Date Closed to Accrual
April 12 2022
Disease Site
Gynecologic [GY]
Cervix
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine if post-operative adjuvant chemo-radiation therapy (CRT) can significantly improve recurrence-free survival (RFS) when compared to radiation therapy (RT) alone in Stage I-IIA cervical cancer patients with intermediate risk factors after treatment with radical hysterectomy.
Patient Population
Post-operative adjuvant chemo-radiation therapy (CRT) or radiation therapy (RT) alone in Stage I-IIA cervical cancer patients with intermediate risk factors after treatment with radical hysterectomy.
Target Accrual
534
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.